Cargando…
Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy
Electroporation improves the anti-tumour efficacy of chemotherapeutic and gene therapies. Combining electroporation-mediated chemotherapeutics with interleukin 12 (IL-12) plasmid DNA produces a strong yet safe anti-tumour effect for treating primary and refractory tumours. A previously published rep...
Autores principales: | Cutrera, Jeffry, King, Glenn, Jones, Pamela, Kicenuik, Kristin, Gumpel, Elias, Xia, Xueqing, Li, Shulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369822/ https://www.ncbi.nlm.nih.gov/pubmed/25628149 http://dx.doi.org/10.1111/jcmm.12382 |
Ejemplares similares
-
WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells
por: Dibra, Denada, et al.
Publicado: (2011) -
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
por: Zhao, Qingnan, et al.
Publicado: (2019) -
Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy
por: Cutrera, Jeffry, et al.
Publicado: (2013) -
IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin
por: Dibra, Denada, et al.
Publicado: (2016) -
CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014)